Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-10-073360
Filing Date
2010-08-05
Accepted
2010-08-05 16:17:56
Documents
5
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c03769e10vq.htm 10-Q 426688
2 EXHIBIT 31.1 c03769exv31w1.htm EX-31.1 5933
3 EXHIBIT 31.2 c03769exv31w2.htm EX-31.2 6212
4 EXHIBIT 32.1 c03769exv32w1.htm EX-32.1 2818
5 EXHIBIT 32.2 c03769exv32w2.htm EX-32.2 2881
  Complete submission text file 0000950123-10-073360.txt   446039
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 033-80623 | Film No.: 10994713
SIC: 2835 In Vitro & In Vivo Diagnostic Substances